Summary
Updated Aug 30, 2026
Seth Loring Harrison files SEC Form 4 reports at Stoke Therapeutics, Inc. (STOK). 3 SEC Form 4 filings on record going back to 2025, most recently on 17 July 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Seth Loring Harrison has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Seth Loring Harrison files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Edward M. Md Kaye - $3.99M of STOK open-market activity in the last 12 months
- Adrian R. Krainer - $3.90M of STOK open-market activity in the last 12 months
- Barry Ticho - $1.92M of STOK open-market activity in the last 12 months
- Jonathan Allan - $1.87M of STOK open-market activity in the last 12 months
- Arthur Tzianabos - $174K of STOK open-market activity in the last 12 months
- Thomas Leggett - $147K of STOK open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Seth Loring Harrison?
Seth Loring Harrison is a corporate insider of Stoke Therapeutics, Inc. (STOK). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Seth Loring Harrison submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Seth Loring Harrison's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Seth Loring Harrison and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
